SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-17-004565
Filing Date
2017-04-28
Accepted
2017-04-28 17:29:44
Documents
8
Period of Report
2017-04-28
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 440797
2 image_001.jpg GRAPHIC 9911
3 image_002.jpg GRAPHIC 2460
4 image_004.jpg GRAPHIC 2610
5 image_005.jpg GRAPHIC 2580
6 image_007.jpg GRAPHIC 32218
7 image_008.jpg GRAPHIC 104692
8 image_006.jpg GRAPHIC 89950
  Complete submission text file 0001493152-17-004565.txt   779225
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37648 | Film No.: 17797367
SIC: 2835 In Vitro & In Vivo Diagnostic Substances